Clinical Trial Update: Inflammation-Induced CNS Glutamate Changes in Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating inflammation-induced CNS glutamate changes in depression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Emory University | Conditions: Depression | Phase 4 | Status: TERMINATED | Results posted: 2023-06-07